{"schema_version":"1","generated_at":"2026-10-30T07:35:41.365Z","data_as_of":null,"url":"https://www.findmykol.com/kol/basem-mishriky","json_url":"https://www.findmykol.com/kol/basem-mishriky/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"basem-mishriky","name":"Basem Mishriky","credential":"MD","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"Duke University Health System","institution_url":"https://www.findmykol.com/institution/duke-university-health-system","city":"Columbia","state":"SC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1326486465","orcid":"0000-0001-7289-5964","openalex":"A5027721713"},"summary":"Basem Mishriky is an Endocrinology/Metabolic physician affiliated with Duke University Health System. OpenAlex indexes 45 publications with 1,227 citations (h-index 15).","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":45,"cited_by_count":1227,"h_index":15,"latest_activity_year":2024,"source":"works"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":15,"shown":3,"withheld":12,"rows":[{"payer":"Novo Nordisk Inc","program_year":2024,"amount_usd":15.11,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326486465"},{"payer":"Abbott Laboratories","program_year":2023,"amount_usd":52.35,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326486465"},{"payer":"Novo Nordisk Inc","program_year":2023,"amount_usd":34.81,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326486465"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1326486465","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":46.9,"classes_total":9,"classes":[{"class":"Statin","setting":"prescribed","share_pct":15.9,"drugs":[{"name":"Atorvastatin Calcium","share_pct":65.1},{"name":"Rosuvastatin Calcium","share_pct":22},{"name":"Pravastatin Sodium","share_pct":8.7},{"name":"Simvastatin","share_pct":4.2}],"max_beneficiaries":124},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":9.1,"drugs":[{"name":"Amlodipine Besylate","share_pct":95.6},{"name":"Amlodipine Besylate-Benazepril","share_pct":4.4}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":25.7,"classes_total":9,"classes":[{"class":"GLP-1 receptor agonist","setting":"prescribed","share_pct":6.2,"drugs":[{"name":"Ozempic","share_pct":61.2},{"name":"Trulicity","share_pct":17.9},{"name":"Mounjaro","share_pct":14.4},{"name":"Rybelsus","share_pct":6.5}],"max_beneficiaries":null},{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":5.6,"drugs":[{"name":"Metformin Hcl","share_pct":55.7},{"name":"Metformin Hcl Er","share_pct":44.3}],"max_beneficiaries":36}]},{"area":"Nervous system","share_pct":11.7,"classes_total":6,"classes":[{"class":"SSRI","setting":"prescribed","share_pct":6.4,"drugs":[{"name":"Sertraline Hcl","share_pct":30.5},{"name":"Trazodone Hcl","share_pct":29.5},{"name":"Fluoxetine Hcl","share_pct":17.6},{"name":"Escitalopram Oxalate","share_pct":15.2},{"name":"Citalopram Hbr","share_pct":7.1}],"max_beneficiaries":null},{"class":"Gabapentinoids","setting":"prescribed","share_pct":3.3,"drugs":[{"name":"Gabapentin","share_pct":84.1},{"name":"Pregabalin","share_pct":15.9}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":43,"shown":5,"withheld":38,"matched_by":"OpenAlex author record","recent":[{"title":"Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data","year":2024,"journal":"Diabetes Obesity and Metabolism","source_url":"https://doi.org/10.1111/dom.15499","status":"verified"},{"title":"Author response for \"Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data\"","year":2024,"source_url":"https://doi.org/10.1111/dom.15499/v2/response1","status":"verified"},{"title":"A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?","year":2023,"journal":"Diabetes/Metabolism Research and Reviews","source_url":"https://doi.org/10.1002/dmrr.3715","status":"verified"},{"title":"102-LB: Cumulative Probability of Mortality among Non-Hispanic Black Compared with Non-Hispanic White Individuals with Type 2 Diabetes on Empagliflozin (EMPA-AA)—Real-World Data","year":2023,"journal":"Diabetes","source_url":"https://doi.org/10.2337/db23-102-lb","status":"verified"},{"title":"Diabetes-Related Microvascular Complications – A Practical Approach","year":2022,"journal":"Primary Care Clinics in Office Practice","source_url":"https://doi.org/10.1016/j.pop.2021.11.008","status":"verified"}],"source":"works"},"contact":{"address_1":"2 MEDICAL PARK RD STE 506","city":"Columbia","state":"SC","zip":"292036876","phone":"803-434-3930","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1326486465","source":"identity"},"similar":[{"name":"Cynthia Guy","slug":"cynthia-guy","institution":"Duke University Health System","specialty":"Anatomic Pathology & Clinical Pathology","url":"https://www.findmykol.com/kol/cynthia-guy","json_url":"https://www.findmykol.com/kol/cynthia-guy/profile.json"},{"name":"Richard Shannon","slug":"richard-shannon","institution":"Duke University Health System","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/richard-shannon","json_url":"https://www.findmykol.com/kol/richard-shannon/profile.json"},{"name":"Gerald Lazarus","slug":"gerald-lazarus","institution":"Duke University Health System","specialty":"Dermatology","url":"https://www.findmykol.com/kol/gerald-lazarus","json_url":"https://www.findmykol.com/kol/gerald-lazarus/profile.json"},{"name":"Suheil Muasher","slug":"suheil-muasher","institution":"Duke University Health System","specialty":"Reproductive Endocrinology","url":"https://www.findmykol.com/kol/suheil-muasher","json_url":"https://www.findmykol.com/kol/suheil-muasher/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":12,"publications":38}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-08-02","provider_certified":"2022-08-02","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}